Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

56
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
56
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

55
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

36
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
36
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Relationship between cardiac implantable electronic devices and tricuspid regurgitation in the general population.

Heart rhythm·2025
Same author

Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.

Ophthalmology·2024
Same author

Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement.

American journal of ophthalmology·2022
Same author

Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?

Frontiers in neuroscience·2022
Same author

Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke.

Pharmacoepidemiology and drug safety·2015
Same author

Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.

Circulation·2015

相关实验视频

Updated: Sep 12, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

作为心脏衰竭的危险因素,左捆支部块是心脏衰竭的危险因素.

Anna-Sophie Thein1,2, Shalini Dixit1, Elsayed Z Soliman3

  • 1Division of Cardiology, Department of Medicine, University of California, San Francisco.

JAMA network open
|August 7, 2025
PubMed
概括

左捆支部阻塞 (LBBB) 在正常心脏结构的个体中显著增加患心力衰竭 (HF) 和左心室喷射率 (LVEF) 降低的风险. 针对LBBB的早期干预可以防止HF的进展.

更多相关视频

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

4.4K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

相关实验视频

Last Updated: Sep 12, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

4.4K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

科学领域:

  • 心脏病学 心脏病学
  • 电力生理学 电力生理学
  • 预防医学 预防医学

背景情况:

  • 左捆支部阻塞 (LBBB) 是心力衰竭 (HF) 的已知危险因素.
  • 在结构正常的心脏和保存左心室喷射分数 (LVEF) 的个体中,LBBB和HF风险之间的关联仍未得到充分研究.

研究的目的:

  • 调查LBBB与社区居住的正常心脏结构的老年人发生高血压风险之间的关联.

主要方法:

  • 一项使用心血管健康研究 (1989-2013) 数据的纵向队列研究.
  • 包括65岁以上的成年人,他们的LVEF正常,以前没有HF诊断.
  • 基线LBBB存在通过心电图确定; 考克斯比例危险模型评估结果.

主要成果:

  • 在4541名参与者中,44名 (1.0%) 在基线时患有LBBB.
  • 在5年内,LBBB与发生性HF风险增加了近5倍 (HR,4.98) 和LVEF下降的概率增加了4.7倍.
  • 在患有LBBB.的人群中,没有观察到任何原因死亡风险的显著增加.

结论:

  • 在结构正常的心脏的个体中,LBBB是发生HF和LVEF下降的重要预测因素.
  • LBBB可以作为旨在预防心脏功能障碍和HF进展的干预措施的早期指标.